GO:0042500 aspartic endopeptidase activity, intramembrane cleaving: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042500 describes aspartic endopeptidase activity that cleaves nonterminal peptide bonds within a membrane, a process known as intramembrane proteolysis.
• The two major enzyme families are presenilins (the catalytic subunit of gamma-secretase) and signal peptide peptidase (SPP) and SPP-like proteases.
• These enzymes use two conserved aspartate residues in transmembrane domains to catalyze peptide bond hydrolysis inside the lipid bilayer.
• Substrates include Notch, amyloid precursor protein (APP), and signal peptides, linking the activity to development, Alzheimer's disease, and lysosomal function.
• Dysregulation is implicated in Alzheimer's disease, cancer, and lysosomal storage disorders, making these proteases important drug targets.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the physiological roles of these intramembrane-cleaving proteases.
Description
Aspartic endopeptidase activity, intramembrane cleaving (GO:0042500) is a molecular function that catalyzes the hydrolysis of nonterminal peptide bonds within a membrane. This unusual proteolytic activity occurs inside the lipid bilayer and is mediated by a distinct class of aspartic proteases, including presenilins and signal peptide peptidase (SPP) and SPP-like proteins. Unlike soluble proteases, these enzymes must accommodate a water molecule and a substrate within the hydrophobic environment of the membrane, a feat achieved through conserved catalytic aspartates in transmembrane domains. The discovery of this activity reshaped our understanding of regulated intramembrane proteolysis (RIP), a signaling mechanism that liberates intracellular domains from membrane-anchored precursors. Researchers study GO:0042500 because it controls diverse biological processes, from Notch signaling in development to amyloid-beta production in Alzheimer's disease. The gamma-secretase complex, which contains presenilin as the catalytic subunit, cleaves APP and Notch, and its dysfunction is central to Alzheimer's disease pathogenesis. Similarly, SPP and SPP-like proteases process signal peptides and are involved in immune surveillance and lysosomal function. Understanding the molecular details of intramembrane cleaving aspartic endopeptidases is therefore critical for developing therapeutics that modulate their activity. This article provides a comprehensive overview of GO:0042500, covering its definition, mechanism, key genes, disease associations, and the experimental models used to study it. We emphasize how CRISPR-based approaches can be leveraged to investigate the function of these proteases in health and disease.
aspartic endopeptidase activity, intramembrane cleaving At A Glance
| GO ID | GO:0042500 |
|---|---|
| GO term | aspartic endopeptidase activity, intramembrane cleaving |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Hydrolysis of nonterminal peptide bonds within a membrane |
| Catalytic residues | Two conserved aspartate residues in transmembrane domains |
| Representative enzymes | Presenilin, signal peptide peptidase (SPP), SPP-like proteases |
| Substrates | Notch, APP, signal peptides |
| Associated diseases | Alzheimer's disease, cancer, lysosomal storage disorders |
What Is GO:0042500?
GO:0042500, aspartic endopeptidase activity, intramembrane cleaving, is defined as the catalysis of the hydrolysis of nonterminal peptide bonds in a polypeptide chain, occurring within a membrane. This activity is carried out by aspartic proteases that possess catalytic aspartate residues within their transmembrane domains. The cleavage event takes place inside the lipid bilayer, distinguishing it from classical soluble proteases.
Why Is aspartic endopeptidase activity, intramembrane cleaving Important in Cell Biology?
GO:0042500 is important because it governs regulated intramembrane proteolysis, a signaling mechanism that controls cell fate decisions, development, and protein quality control. The gamma-secretase complex, which contains presenilin, is essential for Notch signaling and is a major therapeutic target in Alzheimer's disease. SPP and SPP-like proteases are involved in immune response and lysosomal biology, and their dysfunction has been linked to lysosomal storage disorders. Moreover, the unusual chemistry of intramembrane proteolysis offers unique opportunities for drug discovery, as inhibitors can be designed to modulate these enzymes with high specificity.
• Regulates Notch signaling, which is critical for cell differentiation and development.
• Produces amyloid-beta peptides from APP, a key event in Alzheimer's disease pathogenesis.
• SPP and SPP-like proteases process signal peptides and are involved in immune surveillance.
• Dysregulation is linked to cancer, neurodegeneration, and lysosomal storage disorders.
• Provides a paradigm for understanding intramembrane proteolysis, a fundamental cellular process.
• Offers targets for therapeutic intervention, including gamma-secretase inhibitors and modulators.
• Enables the study of membrane protein dynamics and substrate recognition.
• Connects to autophagy and lysosomal function through SPP-like proteases.
• Influences cellular stress responses and protein homeostasis.
• Facilitates the development of CRISPR-based disease models for drug screening.
What Happens During aspartic endopeptidase activity, intramembrane cleaving?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs its target protein inside the membrane.
Intramembrane-cleaving aspartic proteases recognize substrates that have a single transmembrane domain, often after prior cleavage by sheddases. The substrate's transmembrane domain interacts with the enzyme's active site, which is buried within the membrane. For gamma-secretase, substrate recognition involves the presenilin subunit and accessory proteins.
Catalytic cleavage within the membrane
In simple terms: The enzyme cuts the target protein while both are inside the oily membrane.
The catalytic mechanism relies on two conserved aspartate residues that activate a water molecule to hydrolyze the peptide bond. This cleavage occurs within the transmembrane domain, releasing a soluble intracellular fragment and a secreted peptide. The reaction is unusual because it takes place in a hydrophobic environment, requiring precise positioning of water and substrate.
Release of cleavage products
In simple terms: The cut pieces are released to do their jobs in the cell.
Cleavage releases an intracellular domain that can translocate to the nucleus and regulate gene expression, as seen with Notch. The extracellular or luminal peptide is secreted or further processed. For APP, gamma-secretase cleavage generates amyloid-beta peptides of varying lengths, with Aβ42 being particularly aggregation-prone.
Regulation by accessory proteins
In simple terms: Helper proteins control when and where the enzyme works.
Gamma-secretase is a complex of presenilin, nicastrin, APH-1, and PEN-2, which are required for activity and stability. SPP and SPP-like proteases also have accessory proteins that modulate their function. Regulation occurs at the level of complex assembly, substrate availability, and post-translational modifications.
Key Genes Involved in GO:0042500 aspartic endopeptidase activity, intramembrane cleaving
The following genes encode the major aspartic endopeptidases with intramembrane-cleaving activity and their essential cofactors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSEN1 | Catalytic subunit of gamma-secretase | Mutations cause early-onset Alzheimer's disease |
| PSEN2 | Catalytic subunit of gamma-secretase | Mutations linked to familial Alzheimer's disease |
| NCSTN | Component of gamma-secretase complex | Required for complex stability and activity |
| APH1A | Component of gamma-secretase complex | Modulates substrate specificity |
| APH1B | Component of gamma-secretase complex | May have distinct roles in development |
| PSENEN | Component of gamma-secretase complex | Essential for presenilin endoproteolysis |
| HM13 | Signal peptide peptidase (SPP) | Processes signal peptides, involved in immune response |
| SPPL2A | SPP-like protease 2A | Regulates B cell development and lysosomal function |
| SPPL2B | SPP-like protease 2B | Processes TNF-alpha and other substrates |
| SPPL2C | SPP-like protease 2C | Testis-specific, function under investigation |
| SPPL3 | SPP-like protease 3 | Regulates glycosylation and Notch signaling |
| APP | Substrate of gamma-secretase | Cleavage produces amyloid-beta |
| NOTCH1 | Substrate of gamma-secretase | Critical for cell fate decisions |
| NOTCH2 | Substrate of gamma-secretase | Involved in development and cancer |
| NOTCH3 | Substrate of gamma-secretase | Mutations cause CADASIL |
| NOTCH4 | Substrate of gamma-secretase | Role in vascular development |
| CD74 | Substrate of SPPL2A | Involved in antigen presentation |
How Is aspartic endopeptidase activity, intramembrane cleaving Regulated?
The activity of intramembrane-cleaving aspartic proteases is regulated at multiple levels. Gamma-secretase complex assembly is tightly controlled, with presenilin endoproteolysis and interaction with nicastrin, APH-1, and PEN-2 being essential for activity. Substrate availability is regulated by prior shedding events, which can be triggered by signaling pathways. Additionally, post-translational modifications and lipid composition of the membrane can influence enzyme activity. SPP and SPP-like proteases are regulated by their own accessory proteins and by cellular stress.
aspartic endopeptidase activity, intramembrane cleaving and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSEN1 | Alzheimer's disease | Knock-in of familial mutations in iPSCs or mice |
| PSEN2 | Alzheimer's disease | Knockout and point mutation models |
| NOTCH1 | T-cell acute lymphoblastic leukemia | Knockout in cancer cell lines |
| HM13 | Immune regulation and lysosomal function | Knockout mice and cell lines |
| SPPL2A | B cell development and immunodeficiency | Knockout models |
Alzheimer's disease
Gamma-secretase, the most studied intramembrane-cleaving aspartic protease, processes APP to generate amyloid-beta peptides. Mutations in PSEN1 and PSEN2 cause early-onset familial Alzheimer's disease by altering the ratio of Aβ42 to Aβ40. Inhibitors and modulators of gamma-secretase have been developed as potential therapeutics, although clinical trials have faced challenges due to mechanism-based toxicity.
Cancer
Notch signaling, which depends on gamma-secretase-mediated cleavage, is frequently dysregulated in cancers such as T-cell acute lymphoblastic leukemia and breast cancer. Gamma-secretase inhibitors have been explored as anti-cancer agents, but their use is limited by gastrointestinal toxicity. SPP-like proteases have also been implicated in cancer cell proliferation and survival.
Lysosomal storage disorders and immune regulation
SPP and SPP-like proteases are involved in lysosomal function and immune responses. SPPL2A deficiency leads to accumulation of CD74 fragments and affects B cell development. Dysregulation of these proteases has been linked to lysosomal storage disorders and immunodeficiency.
From aspartic endopeptidase activity, intramembrane cleaving-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PSEN1 mutation alter APP processing? | Knock-in of PSEN1 mutations in HEK293 or iPSCs |
| What is the role of SPP in signal peptide processing? | Knockout of HM13 in cell lines |
| How does SPPL2A affect B cell development? | Knockout mice |
| Can gamma-secretase activity be modulated by small molecules? | Overexpression of gamma-secretase subunits in cells |
| What is the effect of Notch1 cleavage on gene expression? | Point mutation of Notch1 cleavage site |
| How does presenilin endoproteolysis affect complex assembly? | Tagged knock-in of PSEN1 |
How to Study the aspartic endopeptidase activity, intramembrane cleaving Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro cleavage assay | Enzymatic activity | Kinetics and inhibitor testing |
| Western blot | Cleavage product levels | APP and Notch processing |
| Luciferase reporter | Transcriptional activation | Notch signaling |
| Co-immunoprecipitation | Protein-protein interactions | Gamma-secretase complex assembly |
| Mass spectrometry | Substrate identification | Proteomic profiling |
| Fluorescence microscopy | Subcellular localization | Organelle-specific cleavage |
| CRISPR knockout | Gene function | Validation of protease roles |
| RNA-seq | Transcriptional changes | Downstream signaling |
Biochemical assays for intramembrane proteolysis
In vitro assays using reconstituted proteoliposomes or membrane fractions can measure cleavage of substrate peptides. Fluorescent or radioactive substrates allow quantification of activity. These assays are essential for studying enzyme kinetics and inhibitor efficacy.
Cell-based reporter assays
Notch and APP cleavage can be monitored using luciferase reporters or Western blotting for cleavage products. These assays are used to screen for modulators of gamma-secretase activity. CRISPR knockout of presenilin or SPP can validate specificity.
Proteomics and interactomics
Mass spectrometry can identify substrates and interacting proteins of intramembrane-cleaving proteases. Co-immunoprecipitation followed by mass spectrometry reveals complex components. These methods help map the substrate repertoire and regulatory networks.
Imaging and subcellular localization
Fluorescence microscopy of tagged proteases and substrates reveals their localization in the ER, Golgi, or lysosomes. Live-cell imaging can track cleavage events in real time. These techniques are crucial for understanding where intramembrane proteolysis occurs.
How CRISPR Can Be Used to Study GO:0042500 aspartic endopeptidase activity, intramembrane cleaving
Knockout
CRISPR knockout of PSEN1, PSEN2, HM13, or SPPL2A can abolish intramembrane-cleaving activity, revealing essential functions in development and disease. Knockout cell lines are valuable for identifying substrates and validating inhibitor specificity.
Point Mutation
Introducing point mutations in catalytic aspartates (e.g., D257A in PSEN1) or in substrate cleavage sites can dissect the mechanism of intramembrane proteolysis. Such models help distinguish between catalytic and structural roles of these proteases.
Knock-in
Knock-in of disease-associated mutations, such as PSEN1 familial Alzheimer's mutations, creates physiologically relevant models for studying altered APP processing. Tagged knock-in of presenilin allows tracking of complex assembly and localization.
Overexpression
Overexpression of gamma-secretase subunits or SPP can enhance cleavage of substrates and facilitate biochemical studies. However, overexpression may saturate the system and produce artifacts, so careful controls are needed.
How EDITGENE Supports aspartic endopeptidase activity, intramembrane cleaving Research
Researchers studying aspartic endopeptidase activity, intramembrane cleaving-related genes often need to determine whether a candidate gene is causally involved in substrate processing, signaling, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of these proteases and their substrates.
Contact EDITGENE today to design your custom CRISPR model for aspartic endopeptidase activity, intramembrane cleaving research.
Frequently Asked Questions About aspartic endopeptidase activity, intramembrane cleaving
What is aspartic endopeptidase activity, intramembrane cleaving?
It is a molecular function (GO:0042500) where an aspartic protease cleaves peptide bonds within a membrane, as seen with presenilin and signal peptide peptidase.
What genes are involved in aspartic endopeptidase activity, intramembrane cleaving?
Key genes include PSEN1, PSEN2, HM13 (SPP), and SPPL2A/B/C, as well as substrates like APP and NOTCH1.
How does intramembrane proteolysis work?
Two conserved aspartate residues in transmembrane domains activate a water molecule to hydrolyze peptide bonds inside the lipid bilayer.
What diseases are associated with GO:0042500?
Alzheimer's disease, cancer, and lysosomal storage disorders are linked to dysfunction of these proteases.
What is the role of presenilin in intramembrane cleavage?
Presenilin is the catalytic subunit of gamma-secretase, which cleaves APP and Notch.
What is signal peptide peptidase (SPP)?
SPP (HM13) is an intramembrane-cleaving aspartic protease that processes signal peptides and is involved in immune regulation.
How can CRISPR be used to study intramembrane proteases?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of these enzymes in cells and animal models.
What are the substrates of gamma-secretase?
Major substrates include APP and Notch receptors, but many others have been identified.
What methods are used to measure intramembrane cleavage?
In vitro cleavage assays, Western blotting, luciferase reporters, and mass spectrometry are commonly used.
Why is intramembrane proteolysis important for drug discovery?
It offers targets for Alzheimer's disease, cancer, and immune disorders, though inhibitor development faces challenges.
Conclusion
GO:0042500, aspartic endopeptidase activity, intramembrane cleaving, represents a unique and biologically critical enzymatic function that operates within the lipid bilayer. Its roles in development, neurodegeneration, and immunity make it a focal point for both basic and translational research. Advances in CRISPR-based models and biochemical assays continue to unravel the complexities of these proteases, offering hope for novel therapeutics.
References
- 1. Steiner H. 2004. Uncovering gamma-secretase.. Curr Alzheimer Res 1(3):175-81 PMID: 15975065
- 2. Schröder B et al.. 2016. Intramembrane proteolysis within lysosomes.. Ageing Res Rev 32:51-64 PMID: 27143694
- 3. Martoglio B et al.. 2003. Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs.. Hum Mol Genet 12 Spec No 2:R201-6 PMID: 12966028
- 4. Haffner C et al.. 2006. Cellular functions of gamma-secretase-related proteins.. Neurodegener Dis 3(4-5):284-9 PMID: 17047369
- 5. Xia W. 2001. Amyloid metabolism and secretases in Alzheimer's disease.. Curr Neurol Neurosci Rep 1(5):422-7 PMID: 11898552
- 6. Xia W et al.. 2003. Intramembrane proteolysis by presenilin and presenilin-like proteases.. J Cell Sci 116(Pt 14):2839-44 PMID: 12808018
- 7. Tsai JY et al.. 2002. The search for gamma-secretase and development of inhibitors.. Curr Med Chem 9(11):1087-106 PMID: 12052174
- 8. Voss M et al.. 2013. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases.. Biochim Biophys Acta 1828(12):2828-39 PMID: 24099004
